News & Analysis on Clinical Trial Services & Contract Research And Development
Enteris has acquired an oral drug delivery platform from Unigene Laboratories and says the excipients used can increase solubility and absorption for both peptides and small molecules.
US and foreign generic drug manufacturers will see a more than $40,000 increase in US FDA facility fees for 2014, while API manufacturers will see a more than $8,000 increase.
Merck & Co. will close the doors on its Kenilworth, New Jersey manufacturing plant affecting 100 jobs in a continuation of its consolidation efforts.
Strides Arcolab received a US FDA Form 483 for an injectables facility that provides for about 25% of subsidiary Agila’s revenues, which is currently in the process of being acquired by Mylan.
CRO Charles River Laboratories saw slight growth in Q2 thanks to its Research Models & Services (RMS) division and two recent acquisitions.